Solventum Q3 Sales Fall 7% but Adjusted EPS Guidance Raised to $7.20-$7.30
SOLV sits 40% above its 52-week low of $62.38 on elevated volume (1.8× avg).
Summary
Solventum's Q3 sales fell 7.0% to $1.949 billion on the expected ERP-related order reversal, but adjusted EPS of $1.45 beat the company's own expectations and full-year adjusted EPS guidance was raised to $7.20-$7.30.
Key Events · Earnings and Guidance · SOLV
-
Q3 Sales Down 7% on ERP Timing
Reported sales of $1.949 billion fell 7.0%, with organic sales down 2.8% reflecting the expected 630 bps reversal of Q2 advance orders placed ahead of the ERP cutover.
-
Adjusted EPS $1.45, GAAP $(0.07)
Adjusted diluted EPS of $1.45 fell 3.6% year over year; GAAP EPS of $(0.07) versus $7.22 reflects the absence of the prior-year $1.518 billion gain on the Purification and Filtration sale.
-
Full-Year Adjusted EPS Guidance Raised
Adjusted EPS outlook lifted to $7.20-$7.30 from $7.10-$7.20, with organic sales growth expected toward the high end of +2.5% to +3.0%.
-
Free Cash Flow Beats on Tariff Refund
Q3 operating cash flow of $177 million and free cash flow of $97 million came in ahead of expectations on an IEEPA tariff refund; full-year free cash flow guidance affirmed at $200-$300 million.
Analysis · SOLV · Industrial Applications And Services
Reported sales fell 7.0% to $1.949 billion, but $1.5 billion of that optics is mechanical: the prior-year quarter carried a $1.518 billion gain on the Purification and Filtration sale, which is why GAAP EPS swung to $(0.07) from $7.22. The number that matters is organic sales, down 2.8% because customers pulled orders forward into Q2 ahead of the ERP cutover — a timing reversal management had already flagged. With that cutover now complete and separation from 3M more than 90% done, Solventum raised full-year adjusted EPS to $7.20-$7.30 from $7.10-$7.20 and pointed organic growth toward the high end of +2.5% to +3.0%. Free cash flow of $97 million in the quarter, helped by an IEEPA tariff refund, supports the affirmed $200-$300 million full-year range.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.2% of the 2649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SOLV was trading at $87.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14.8B. The 52-week trading range was $62.38 to $94.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.